Largest health care companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Revolution Medicines has the lowest figure of the 158 health care companies ranked by revenue, at CHF 0, followed by Spyre Therapeutics (CHF 0) and Praxis Precision Medicines (CHF 0). Figures as of 19 Nov 2026, 11:03 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 158
- Lowest
- Revolution MedicinesCHF 0
- Median
- CHF 3.4B
- Combined market value
- CHF 7.66T
- Countries
- 14
- Not ranked
- 12no revenue on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Revenue ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Revolution MedicinesRVMD · Health Care | CHF 0 | CHF 29.1B | CHF 134.58 | 1.76% down | 131% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | CHF 0 | CHF 8.1B | CHF 85.44 | 8.15% up | 286% up | ||
| 3 | Praxis Precision MedicinesPRAX · Health Care | CHF 0 | CHF 7.2B | CHF 256.99 | 0.04% up | 61% up | ||
| 4 | Scholar Rock HoldingSRRK · Health Care | CHF 0 | CHF 4.9B | CHF 40.42 | 6.48% up | 14% up | ||
| 5 | Dianthus TherapeuticsDNTH · Health Care | CHF 1.7M | CHF 4B | CHF 70.72 | 3.45% down | 113% up | ||
| 6 | CRISPR TherapeuticsCRSP · Health Care | CHF 3M | CHF 3.3B | CHF 33.84 | 0.10% up | 21% down | ||
| 7 | CG OncologyCGON · Health Care | CHF 3.4M | CHF 6B | CHF 67.37 | 1.34% up | 85% up | ||
| 8 | Roivant SciencesROIV · Health Care | CHF 7M | CHF 23.6B | CHF 32.61 | 0.05% up | 90% up | ||
| 9 | Kymera TherapeuticsKYMR · Health Care | CHF 33M | CHF 8.7B | CHF 102.00 | 0.32% down | 87% up | ||
| 10 | Protagonist TherapeuticsPTGX · Health Care | CHF 38.7M | CHF 7B | CHF 107.08 | 2.00% up | 46% up | ||
| 11 | CytokineticsCYTK · Health Care | CHF 74.1M | CHF 6B | CHF 43.22 | 0.64% down | 20% down | ||
| 12 | ImmunityBioIBRX · Health Care | CHF 95.4M | CHF 6B | CHF 5.64 | 7.03% up | 193% up | ||
| 13 | GRAILGRAL · Health Care | CHF 123.9M | CHF 3.9B | CHF 85.98 | 3.57% down | 20% up | ||
| 14 | HeartflowHTFL · Health Care | CHF 148.2M | CHF 3.4B | CHF 38.64 | 2.51% down | 73% up | ||
| 15 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 159.8M | CHF 6.9B | CHF 100.24 | 2.08% up | 13% up | ||
| 16 | Ligand PharmaceuticalsLGND · Health Care | CHF 225.8M | CHF 5B | CHF 251.54 | 1.67% up | 43% up | ||
| 17 | Adaptive BiotechnologiesADPT · Health Care | CHF 233.2M | CHF 3.9B | CHF 23.97 | 0.11% down | 88% up | ||
| 18 | BillionToOneBLLN · Health Care | CHF 256.9M | CHF 3.7B | CHF 77.08 | 6.11% down | 0% up | ||
| 19 | Twist BioscienceTWST · Health Care | CHF 317.1M | CHF 6.7B | CHF 97.98 | 3.88% up | 340% up | ||
| 20 | Krystal BiotechKRYS · Health Care | CHF 327.7M | CHF 7.9B | CHF 265.54 | 5.62% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | CHF 413.2M | CHF 4.1B | CHF 42.31 | 1.68% down | 44% up | ||
| 22 | BridgeBio PharmaBBIO · Health Care | CHF 422.8M | CHF 12.8B | CHF 65.69 | 1.58% up | 17% up | ||
| 23 | GlaukosGKOS · Health Care | CHF 427.3M | CHF 11.6B | CHF 196.27 | 4.18% down | 152% up | ||
| 24 | Mirum PharmaceuticalsMIRM · Health Care | CHF 439M | CHF 5.1B | CHF 77.88 | 0.59% up | 31% up | ||
| 25 | InsmedINSM · Health Care | CHF 510.7M | CHF 22.1B | CHF 100.88 | 1.69% down | 40% down | ||
| 26 | TG TherapeuticsTGTX · Health Care | CHF 519M | CHF 8.4B | CHF 55.68 | 5.44% up | 107% up | ||
| 27 | Axsome TherapeuticsAXSM · Health Care | CHF 537.7M | CHF 5.9B | CHF 112.84 | 1.43% down | 7% down | ||
| 28 | 10x GenomicsTXG · Health Care | CHF 541.3M | CHF 6.3B | CHF 48.06 | 1.37% up | 260% up | ||
| 29 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 570.6M | CHF 6.3B | CHF 80.04 | 0.06% down | 126% up | ||
| 30 | RepligenRGEN · Health Care | CHF 621.7M | CHF 9.3B | CHF 145.40 | 6.47% up | 5% up | ||
| 31 | Corcept TherapeuticsCORT · Health Care | CHF 641.2M | CHF 6.2B | CHF 57.08 | 3.25% down | 8% down | ||
| 32 | Ascendis PharmaASND · Health Care | CHF 672.8M | CHF 14.9B | CHF 227.64 | 0.32% down | 28% up | ||
| 33 | Caris Life SciencesCAI · Health Care | CHF 683.8M | CHF 4.7B | CHF 16.42 | 2.21% down | 17% down | ||
| 34 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 698.5M | CHF 5.1B | CHF 36.30 | 0.28% up | 10% up | ||
| 35 | Ionis PharmaceuticalsIONS · Health Care | CHF 794.7M | CHF 3.8B | CHF 23.06 | 1.59% up | 64% down | ||
| 36 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 807.1M | CHF 7.8B | CHF 335.22 | 5.67% down | 24% down | ||
| 37 | Guardant HealthGH · Health Care | CHF 826.9M | CHF 16.5B | CHF 122.22 | 1.30% up | 44% up | ||
| 38 | Legend BiotechLEGN · Health Care | CHF 866.4M | CHF 2.7B | CHF 13.68 | 0.87% up | 42% down | ||
| 39 | Bio-TechneTECH · Health Care | CHF 1B | CHF 9.6B | CHF 61.26 | 0.17% up | 26% up | ||
| 40 | HealthEquityHQY · Health Care | CHF 1.1B | CHF 6.8B | CHF 81.94 | 4.45% down | 2% down | ||
| 41 | HaemoneticsHAE · Health Care | CHF 1.1B | CHF 4.7B | CHF 103.46 | 1.60% up | 61% up | ||
| 42 | LivaNovaLIVN · Health Care | CHF 1.2B | CHF 4.4B | CHF 79.61 | 2.85% up | 71% up | ||
| 43 | Halozyme TherapeuticsHALO · Health Care | CHF 1.2B | CHF 9.2B | CHF 80.67 | 0.18% down | 37% up | ||
| 44 | PenumbraPEN · Health Care | CHF 1.2B | CHF 10.6B | CHF 269.97 | 0.47% up | 13% up | ||
| 45 | LifeStance Health GroupLFST · Health Care | CHF 1.2B | CHF 4.4B | CHF 11.60 | 2.82% down | 129% up | ||
| 46 | AlkermesALKS · Health Care | CHF 1.2B | CHF 6.6B | CHF 39.45 | 3.08% up | 58% up | ||
| 47 | Merit Medical SystemsMMSI · Health Care | CHF 1.3B | CHF 4.3B | CHF 72.36 | 1.70% up | 1% up | ||
| 48 | Lantheus HoldingsLNTH · Health Care | CHF 1.3B | CHF 5.6B | CHF 85.89 | 0.20% up | 93% up | ||
| 49 | PTC TherapeuticsPTCT · Health Care | CHF 1.5B | CHF 4.2B | CHF 50.72 | 0.22% down | 20% down | ||
| 50 | MSA SafetyMSA · Health Care | CHF 1.6B | CHF 5.8B | CHF 149.43 | 2.67% up | 11% up | ||
| 51 | ModernaMRNA · Health Care | CHF 1.6B | CHF 67.1B | CHF 165.71 | 4.84% down | 755% up | ||
| 52 | TeleflexTFX · Health Care | CHF 1.7B | CHF 5.5B | CHF 139.66 | 3.95% up | 51% up | ||
| 53 | RadNetRDNT · Health Care | CHF 1.7B | CHF 4.8B | CHF 60.48 | 4.14% down | 7% down | ||
| 54 | QiagenQGEN · Health Care | CHF 1.8B | CHF 8.6B | CHF 41.73 | 0.38% down | 12% up | ||
| 55 | Concentra Group Holdings ParentCON · Health Care | CHF 1.8B | CHF 4.4B | CHF 35.35 | 0.94% down | 120% up | ||
| 56 | NateraNTRA · Health Care | CHF 1.9B | CHF 35.3B | CHF 243.78 | 0.71% up | 32% up | ||
| 57 | ExelixisEXEL · Health Care | CHF 2B | CHF 14B | CHF 57.51 | 0.31% down | 63% up | ||
| 58 | Hims & Hers HealthHIMS · Health Care | CHF 2B | CHF 3.4B | CHF 14.36 | 2.85% down | 51% down | ||
| 59 | Royalty PharmaRPRX · Health Care | CHF 2B | CHF 33.2B | CHF 57.83 | 0.01% down | 78% up | ||
| 60 | ChemedCHE · Health Care | CHF 2.1B | CHF 6B | CHF 460.38 | 0.01% down | 27% up | ||
| 61 | Medpace HoldingsMEDP · Health Care | CHF 2.1B | CHF 15.2B | CHF 544.72 | 0.95% down | 10% up | ||
| 62 | Bio-Rad LaboratoriesBIO · Health Care | CHF 2.2B | CHF 8.4B | CHF 311.71 | 3.34% up | 18% up | ||
| 63 | InsuletPODD · Health Care | CHF 2.3B | CHF 8.2B | CHF 117.87 | 3.69% down | 58% down | ||
| 64 | RevvityRVTY · Health Care | CHF 2.4B | CHF 14.3B | CHF 128.36 | 3.14% up | 60% up | ||
| 65 | Neurocrine BiosciencesNBIX · Health Care | CHF 2.4B | CHF 13.9B | CHF 137.14 | 1.84% down | 20% up | ||
| 66 | Globus MedicalGMED · Health Care | CHF 2.5B | CHF 7.9B | CHF 59.39 | 0.77% up | 16% down | ||
| 67 | Amneal PharmaceuticalsAMRX · Health Care | CHF 2.5B | CHF 6.4B | CHF 18.42 | 3.60% up | 83% up | ||
| 68 | West Pharmaceutical ServicesWST · Health Care | CHF 2.6B | CHF 23.7B | CHF 340.22 | 2.44% down | 61% up | ||
| 69 | MiniMed GroupMMED · Health Care | CHF 2.6B | CHF 4B | CHF 14.31 | 4.44% down | 4% down | ||
| 70 | WatersWAT · Health Care | CHF 2.7B | CHF 77.1B | CHF 392.49 | 3.63% up | 20% up | ||
| 71 | United TherapeuticsUTHR · Health Care | CHF 2.7B | CHF 20.7B | CHF 486.17 | 1.16% down | 23% up | ||
| 72 | BioNTechBNTX · Health Care | CHF 2.7B | CHF 17.4B | CHF 70.11 | 1.89% down | 16% down | ||
| 73 | BioMarin PharmaceuticalBMRN · Health Care | CHF 2.7B | CHF 10B | CHF 51.73 | 4.99% up | 11% up | ||
| 74 | BrukerBRKR · Health Care | CHF 2.9B | CHF 8.1B | CHF 53.27 | 3.10% up | 41% up | ||
| 75 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 3B | CHF 10.5B | CHF 12.61 | 1.28% up | 5% up | ||
| 76 | Alnylam PharmaceuticalsALNY · Health Care | CHF 3.1B | CHF 16.9B | CHF 125.81 | 4.54% down | 66% down | ||
| 77 | GenmabGMAB · Health Care | CHF 3.1B | CHF 26.5B | CHF 42.92 | 1.91% down | 70% up | ||
| 78 | Charles River Laboratories InternationalCRL · Health Care | CHF 3.4B | CHF 13.4B | CHF 280.62 | 0.33% up | 105% up | ||
| 79 | Mettler-Toledo InternationalMTD · Health Care | CHF 3.4B | CHF 29.1B | CHF 1,462.91 | 1.42% up | 22% up | ||
| 80 | Align TechnologyALGN · Health Care | CHF 3.4B | CHF 9.7B | CHF 138.07 | 0.31% up | 22% up | ||
| 81 | Cooper CompaniesCOO · Health Care | CHF 3.4B | CHF 9.7B | CHF 51.16 | 0.05% up | 16% down | ||
| 82 | argenxARGX · Health Care | CHF 3.5B | CHF 49.8B | CHF 792.61 | 0.66% down | 4% up | ||
| 83 | Jazz PharmaceuticalsJAZZ · Health Care | CHF 3.6B | CHF 13.4B | CHF 208.64 | 2.93% up | 37% up | ||
| 84 | IDEXX LaboratoriesIDXX · Health Care | CHF 3.6B | CHF 46.3B | CHF 588.17 | 1.19% up | 1% down | ||
| 85 | IlluminaILMN · Health Care | CHF 3.7B | CHF 26.7B | CHF 176.85 | 3.65% up | 69% up | ||
| 86 | DexComDXCM · Health Care | CHF 3.9B | CHF 25.9B | CHF 69.49 | 0.59% up | 37% up | ||
| 87 | Elanco Animal HealthELAN · Health Care | CHF 4B | CHF 11.2B | CHF 22.48 | 3.29% up | 20% up | ||
| 88 | Ensign GroupENSG · Health Care | CHF 4.3B | CHF 9B | CHF 154.08 | 1.63% down | 4% up | ||
| 89 | Bausch + LombBLCO · Health Care | CHF 4.3B | CHF 6.3B | CHF 17.64 | 0.58% up | 42% up | ||
| 90 | IncyteINCY · Health Care | CHF 4.3B | CHF 20.2B | CHF 99.20 | 1.08% down | 18% up | ||
| 91 | PACS GroupPACS · Health Care | CHF 4.5B | CHF 6.2B | CHF 38.99 | 4.63% down | 188% up | ||
| 92 | BeOne MedicinesONC · Health Care | CHF 4.5B | CHF 38.8B | CHF 339.86 | 2.34% down | 17% up | ||
| 93 | Option Care HealthOPCH · Health Care | CHF 4.8B | CHF 4B | CHF 26.70 | 0.25% up | 14% up | ||
| 94 | ResMedRMD · Health Care | CHF 4.8B | CHF 28.7B | CHF 204.30 | 2.00% up | 3% down | ||
| 95 | Encompass HealthEHC · Health Care | CHF 5B | CHF 11.1B | CHF 113.62 | 2.14% down | 23% up | ||
| 96 | STERISSTE · Health Care | CHF 5B | CHF 21.2B | CHF 218.58 | 0.84% up | 1% up | ||
| 97 | Edwards LifesciencesEW · Health Care | CHF 5.1B | CHF 51B | CHF 88.61 | 0.19% down | 23% up | ||
| 98 | Smith & NephewSNN · Health Care | CHF 5.2B | CHF 10.7B | CHF 25.53 | 0.62% down | 5% down | ||
| 99 | AvantorAVTR · Health Care | CHF 5.5B | CHF 8.8B | CHF 12.94 | 1.25% up | 38% up | ||
| 100 | Agilent TechnologiesA · Health Care | CHF 5.9B | CHF 42.1B | CHF 149.33 | 2.97% up | 19% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8421 CHF). 12 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care companies have the lowest revenue?
Revolution Medicines (CHF 0), Spyre Therapeutics (CHF 0) and Praxis Precision Medicines (CHF 0) have the lowest revenue of the 158 health care companies ranked here as of 19 Nov 2026, 11:03 UTC.
How many health care companies are in this ranking?
158 are ranked by revenue. 12 more have no revenue on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 158 health care companies ranked by revenue have a combined market value of CHF 7.66T as of 19 Nov 2026, 11:03 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by revenue”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.